A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Samsung Biologics signs a US$411.3M deal to make Pfizer's biosimilar products at its recently completed Plant 4 facility in Songdo, South Korea; biosimilars involved in the deal include oncology, inflammation and immunotherapy products
Published: June 08, 2023 by Yonhap News Agency (South Korea)
Pfizer Applies for Patent on Pyrrolo[2,3-D]Pyrimidine Derivatives
Published: June 08, 2023 by Pharmaceutical Patent News
Promosome LLC Sues Moderna, Pfizer, and BioNTech for COVID-19 Vaccine Patent Infringement
Published: June 07, 2023 by Associated Press
Alnylam files new COVID-19 vaccine infringement lawsuits that allege Pfizer's and Moderna's COVID-19 vaccine lipid nanoparticle technology infringes Alnylam's patent rights
Published: June 06, 2023 by Mondaq Business Briefing
Pfizer Inc Applies for Patent on Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-Yl)Amino)-N-(1-(2-Methyl-1-(Neopentylamino)Propan-2-Yl)-1h-Imidazol-4-Yl)Pentanamide and Uses Thereof
Published: June 06, 2023 by Pharmaceutical Patent News

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count